[go: up one dir, main page]

GB2002758A - Neuromuscular blocking agents - Google Patents

Neuromuscular blocking agents

Info

Publication number
GB2002758A
GB2002758A GB7831697A GB7831697A GB2002758A GB 2002758 A GB2002758 A GB 2002758A GB 7831697 A GB7831697 A GB 7831697A GB 7831697 A GB7831697 A GB 7831697A GB 2002758 A GB2002758 A GB 2002758A
Authority
GB
United Kingdom
Prior art keywords
blocking agents
neuromuscular blocking
carbon atoms
image
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB7831697A
Other versions
GB2002758B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of GB2002758A publication Critical patent/GB2002758A/en
Application granted granted Critical
Publication of GB2002758B publication Critical patent/GB2002758B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18Aralkyl radicals
    • C07D217/20Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

Short acting reversible neuromuscular blocking agents of the formula: <IMAGE> where B and C are para or preferably meta, and each is <IMAGE> where m is 2, 3 or 4 and is preferably 2, R1, R2, R3, R4, R5, R6 and R7 are the same or different and are hydrogen or alkoxy of 1 to 4 carbon atoms, Y is alkyl of 1 to 4 carbon atoms, n is 2, 3 or 4, most preferably 3, provided that at least one of R1 to R4 and one of R5 to R7 is lower alkoxy, and X is a pharmaceutically acceptable anion are useful upon administration to a patient in providing muscular relaxation in the patient during surgery and are normally intravenously administered in a pharmaceutically acceptable carrier.
GB7831697A 1977-08-01 1978-07-31 Neuromuscular blocking agents Expired GB2002758B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82079477A 1977-08-01 1977-08-01

Publications (2)

Publication Number Publication Date
GB2002758A true GB2002758A (en) 1979-02-28
GB2002758B GB2002758B (en) 1982-02-03

Family

ID=25231743

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7831697A Expired GB2002758B (en) 1977-08-01 1978-07-31 Neuromuscular blocking agents

Country Status (21)

Country Link
JP (1) JPS5455577A (en)
AT (1) AT368496B (en)
AU (1) AU523706B2 (en)
BE (1) BE869415A (en)
CA (1) CA1113096A (en)
DD (1) DD143254A5 (en)
DE (1) DE2833505A1 (en)
DK (1) DK339078A (en)
ES (1) ES472229A1 (en)
FI (1) FI782363A7 (en)
FR (1) FR2399429A1 (en)
GB (1) GB2002758B (en)
IE (1) IE47014B1 (en)
IL (1) IL55254A (en)
LU (1) LU80062A1 (en)
MC (1) MC1197A1 (en)
NL (1) NL7808067A (en)
PL (1) PL121492B1 (en)
SE (1) SE7808267L (en)
SU (1) SU862820A3 (en)
ZA (1) ZA784331B (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0010119A1 (en) * 1978-07-21 1980-04-30 The Massachusetts General Hospital Isoquinoline derivatives, their preparation and pharmaceutical compositions containing these compounds
US4235906A (en) 1978-07-21 1980-11-25 Massachusetts General Hospital Bis-isoquinolinium compounds, compositions and methods of use
EP0080682A1 (en) * 1981-11-23 1983-06-08 The Wellcome Foundation Limited Bisisoquinolinium compound, pharmaceutical compositions and synthesis
JPS6187666A (en) * 1984-07-18 1986-05-06 ザ ウエルカム フアウンデ−シヨン リミテツド New compounds, their preparation and use as muscle relaxants
WO1998042675A1 (en) * 1997-03-25 1998-10-01 Glaxo Group Limited Substituted isoquinolines as ultra short acting neuromuscular blockers
CN114057642A (en) * 2021-12-10 2022-02-18 广东嘉博制药有限公司 Synthetic method of mikui ammonium chloride intermediate

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5645459A (en) * 1979-09-20 1981-04-25 Otsuka Pharmaceut Co Ltd Cyclic amine
JPH0555438A (en) * 1991-08-26 1993-03-05 Rohm Co Ltd Lead terminal structure of electronic component
EP2101772B1 (en) * 2006-12-06 2012-04-25 Cornell Research Foundation, Inc. Intermediate duration neuromuscular blocking agents and antagonists thereof
WO2010107488A1 (en) 2009-03-17 2010-09-23 Cornell University Reversible nondepolarizing neuromuscular blockade agents and methods for their use
CN102573794B (en) 2009-08-19 2017-03-15 康奈尔大学 Cysteine for physiologic infusion

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5156762U (en) * 1974-10-28 1976-05-04

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0010119A1 (en) * 1978-07-21 1980-04-30 The Massachusetts General Hospital Isoquinoline derivatives, their preparation and pharmaceutical compositions containing these compounds
US4235906A (en) 1978-07-21 1980-11-25 Massachusetts General Hospital Bis-isoquinolinium compounds, compositions and methods of use
EP0080682A1 (en) * 1981-11-23 1983-06-08 The Wellcome Foundation Limited Bisisoquinolinium compound, pharmaceutical compositions and synthesis
JPS6187666A (en) * 1984-07-18 1986-05-06 ザ ウエルカム フアウンデ−シヨン リミテツド New compounds, their preparation and use as muscle relaxants
EP0181055A1 (en) * 1984-07-18 1986-05-14 The Wellcome Foundation Limited Bis-dimethoxymethyl (trimethoxybenzyl)isoquinolinium salts, their preparation and pharmaceutical compositions containing them
US4761418A (en) * 1984-07-18 1988-08-02 Burroughs Wellcome Co. Novel compounds
JPH0662568B2 (en) 1984-07-18 1994-08-17 ザ ウエルカム フアウンデ−シヨン リミテツド Novel compound, its preparation method and use as muscle relaxant
WO1998042675A1 (en) * 1997-03-25 1998-10-01 Glaxo Group Limited Substituted isoquinolines as ultra short acting neuromuscular blockers
US6177445B1 (en) * 1997-03-25 2001-01-23 Glaxo Wellcome Inc. Substituted isoquinolines as ultra short acting neuromuscular blockers
EP1380573A3 (en) * 1997-03-25 2004-01-21 Avera Pharmaceuticals, Inc. Isoquinolines and preparation thereof
EP1526130A1 (en) * 1997-03-25 2005-04-27 Avera Pharmaceuticals, Inc. Substituted isoquinolines as ultra short acting neuromuscular blockers
CN114057642A (en) * 2021-12-10 2022-02-18 广东嘉博制药有限公司 Synthetic method of mikui ammonium chloride intermediate

Also Published As

Publication number Publication date
FI782363A7 (en) 1979-02-02
IE781550L (en) 1979-02-01
IL55254A (en) 1983-03-31
SE7808267L (en) 1979-02-02
AU3847678A (en) 1980-02-07
ATA555478A (en) 1982-02-15
FR2399429A1 (en) 1979-03-02
DE2833505A1 (en) 1979-04-05
PL121492B1 (en) 1982-05-31
AU523706B2 (en) 1982-08-12
IL55254A0 (en) 1978-09-29
NL7808067A (en) 1979-02-05
BE869415A (en) 1979-01-31
AT368496B (en) 1982-10-11
DD143254A5 (en) 1980-08-13
CA1113096A (en) 1981-11-24
PL208757A1 (en) 1979-06-04
JPS5455577A (en) 1979-05-02
GB2002758B (en) 1982-02-03
LU80062A1 (en) 1979-05-15
MC1197A1 (en) 1979-03-19
DK339078A (en) 1979-02-02
FR2399429B1 (en) 1981-07-17
ZA784331B (en) 1979-12-27
IE47014B1 (en) 1983-11-30
SU862820A3 (en) 1981-09-07
ES472229A1 (en) 1979-03-16

Similar Documents

Publication Publication Date Title
ES454779A1 (en) Etherified hydroxy-benzodiheterocyclic compounds
GB2002758A (en) Neuromuscular blocking agents
ATE60759T1 (en) BISDIMETHOXYMETHYL(TRIMETHOXYBENZYL)ISOCHINOLINIUM SALTS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
PA8401801A1 (en) NEUROMUSCULAR BLOCKING AGENTS
KR890003691A (en) Piperidine derivatives and therapeutic prophylaxis for arrhythmias containing them
MY124465A (en) Reduction of infarct volume using citicoline
FR2457278A1 (en) THERAPEUTIC USE OF 9-AMINOALKYLFLUORENES
GB9108629D0 (en) Heterocyclic pharmaceutical compounds,preparation and use
ES8401489A1 (en) Pyrido(3,4-c)psoralenes, preparation, use in cosmetology and in medicine and compositions containing them.
NO158677C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ISOXSAZOL DERIVATIVES.
ES475533A1 (en) Novel propione amide derivative and its manufacture
FR2404627A1 (en) DICHLORACETAMIDES DISUBSTITUTED IN NITROGEN, THEIR PREPARATION AND THEIR USE, ESPECIALLY IN THE TREATMENT OF AMIBIASES
UA41329C2 (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT OF HEART RATE DISORDERS IN LARGE MAMMALS AND HUMANS, DERIVATIVES OF 3-PHENYLSULPHONYL-3,7-DIAZ
BE864822A (en) NITROGEN AROMATIC DERIVATIVES OF ACETAMIDE, THEIR PREPARATION AND THEIR THERAPEUTIC USE AS ANTI-ARRHYTHMICS
IE790108L (en) Isoquinoline compounds
GB2129425B (en) 5-halovinyl-2&#39;-deoxyuridine derivatives
CA2126208A1 (en) Anti-Obesity Agent
PL221331A2 (en)
IL126795A0 (en) Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders
FR2457868A1 (en) IMIDAZOBENZODIAZEPINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USES
GB2000029A (en) Anthraquinones for Cancer Therapy
ES456639A1 (en) Cyclopenta{8 B{9 thiophene derivatives
ES438537A1 (en) 1-(2,4,6-Trihydroxyphenyl)-propanedione-(1,2)-compounds and therapeutic compositions
FR2416890A1 (en) 1,5-BENZOTHIAZEPINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USES
ES465221A1 (en) 4-Tert. butyl-3&#39;-chlorodiphenylamine derivatives, their preparation and their application as anti-histaminic drugs

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee